ArticleCancers2018
The Transition between Telomerase and ALT Mechanisms in Hodgkin Lymphoma and Its Predictive Value in Clinical Outcomes.
Open access · goldAbstract read
In one paragraph
Article in Cancers, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 21 citations in OpenAlex.
- Review
- Telomeric Ends and Telomerase-Canonical and Non-Canonical Roles in Breast Cancer Tumorigenesis and Therapy Resistance.Biomedicines · 2026Review
- The role of telomeres in leukemic stem cells function.Regenerative therapy · 2025Review
- Three-Dimensional Organization of Telomeres: An Emerging Prognostic Biomarker in Multiple Myeloma.Cells · 2025Review
- Beyond Telomeres: Unveiling the Extratelomeric Functions of TERT in B-Cell Malignancies.Cancers · 2025Review
- DNA Damage, Telomere and Centromere Dysfunction in Chromothripsis Rearrangements.Methods in molecular biology (Clifton, N.J.) · 2025Article
- Review
- Article
- Article
- Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.Cell reports · 2023Article
- Consecutive Inhibition of Telomerase and Alternative Lengthening Pathway Promotes Hodgkin's Lymphoma Cell Death.Biomedicines · 2022Article
- Article
- Telomere Dysfunction Is Associated with Altered DNA Organization in Trichoplein/Tchp/Mitostatin (TpMs) Depleted Cells.Biomedicines · 2022Article
- TGS1 mediates 2,2,7-trimethyl guanosine capping of the human telomerase RNA to direct telomerase dependent telomere maintenance.Nature communications · 2022Article
- A Role for Human DNA Polymerase λ in Alternative Lengthening of Telomeres.International journal of molecular sciences · 2021Article
- Novel therapeutic strategies targeting telomere maintenance mechanisms in high-risk neuroblastoma.Journal of experimental & clinical cancer research : CR · 2020Review
- The Use of Natural Agents to Counteract Telomere Shortening: Effects of a Multi-Component Extract ofBiomedicines · 2020Article
- Article
- Independent Mechanisms Lead to Genomic Instability in Hodgkin Lymphoma: Microsatellite or Chromosomal InstabilityCancers · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
22 authors at 9 institutions in 3 countries.
Radhia M'kacherLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. radhia.mkacher@gmail.com.
Corina CuceuLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. cuceu_corina@yahoo.com.
Mustafa Al JawhariLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. mustafa.aljawhari@hotmail.fr.
Luc MoratLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. luc.morat@cea.fr.
Monika FrenzelLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. monika.frenzel@hotmail.com.
Grace ShimLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. graceshim1@gmail.com.
Aude LenainLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. audelenain@yahoo.fr.
William M HempelLaboratoire de Radiobiologie et d'Oncologie, IRCM/DSV/CEA, 92265 Fontenay aux Roses, France. williamhempel824@gmail.com.
Steffen JunkerInstitute of Biomedicine, University of Aarhus, DK-8000 Aarhus C, Denmark. sjunker@biomed.au.dk.
Theodore GirinskyDepartment of Radiation Therapy, Gustave Roussy Cancer Campus, 94808 Villejuif, France. theogirinsky@me.com.
Bruno ColicchioIRIMAS, Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, 68093 Mulhouse, France. bruno.colicchio@uha.fr.
Alain DieterlenIRIMAS, Institut de Recherche en Informatique, Mathématiques, Automatique et Signal, Université de Haute-Alsace, 68093 Mulhouse, France. alain.dieterlen@uha.fr.
Leonhard HeidingsfelderMetaSystems GmbH, Robert-Bosch-Str. 6, D-68804 Altlussheim, Germany. lheidingsfelder@metasystems.de.
Claire BorieUniversité Paris Sud, Service d'hématologie moléculaire et cytogénétique Paul brousse CHU paris Sud, Inserm UMRS935, 94800 Villejuif, France. claire.borie@aphp.fr.
Noufissa OudrhiriUniversité Paris Sud, Service d'hématologie moléculaire et cytogénétique Paul brousse CHU paris Sud, Inserm UMRS935, 94800 Villejuif, France. noufissa.oudrhiri@aphp.fr.
Annelise Bennaceur-GriscelliUniversité Paris Sud, Service d'hématologie moléculaire et cytogénétique Paul brousse CHU paris Sud, Inserm UMRS935, 94800 Villejuif, France. annelise.bennaceur@aphp.fr.
Olivier MoralèsCNRS, Institut Pasteur de Lille, UMR 8161-Immunoregulation of Virus-induced Cancers Team, F-59000 Lille, France. olivier.morales@ibl.cnrs.fr.
Sarah RenaudCNRS, Institut Pasteur de Lille, UMR 8161-Immunoregulation of Virus-induced Cancers Team, F-59000 Lille, France. sarah.renaud@ibl.cnrs.fr.
Zoé Van de WyngaertCHRU Lille Service des Maladies du Sang, Hopital Huriez, 59000 Lille, France. zoe.vdw@gmail.com.ORCID 0000-0001-9463-2823
Eric JeandidierService de génétique, Groupe hospitalier de la région de Mulhouse Sud-Alsace, 68093 Mulhouse, France. jeandidiere@ghrmsa.fr.
Nadira DelhemCNRS, Institut Pasteur de Lille, UMR 8161-Immunoregulation of Virus-induced Cancers Team, F-59000 Lille, France. nadira.delhem@ibl.cnrs.fr.
Patrice CardeDepartment of Medicine, Gustave Roussy Cancer Campus, 94808 Villejuif, France. dr.pcarde@gmail.com.
Commissariat à l'Énergie Atomique et aux Énergies Alternatives · FRCentre National de la Recherche Scientifique · FRUniversité Paris-Sud · FRInstitut Gustave Roussy · FRUniversité de Haute-Alsace · FRAarhus University · DKGroupe Hospitalier de la Région de Mulhouse et Sud Alsace · FRHôpital Claude Huriez · FRRobert Bosch (Germany) · DE
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
alternative lengthening of telomeresEBVHodgkin Lymphomatelomerase
Identifiers
What Socratic holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.